Biomedical applications of nanotechnology--implications for drug targeting and gene therapy

Trends in Biotechnology
S S Davis

Abstract

Colloidal particles in the nanometre size range (less than 1 micron in diameter) can be engineered to provide opportunities for the site-specific delivery of drugs after injection into the general circulation or lymphatic systems. Targets include the liver (both Kupffer cells and hepatocytes), endothelial cells, sites of inflammation and lymph nodes. The size and surface of the particle are crucial factors in targeting, and the attachment of cell-specific ligands can lead to increased selectivity. The applications of such particle engineering are discussed in relation to conventional drugs as well as the emerging area of gene therapy.

References

Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R StriblingR Debs
Jun 1, 1992·Anti-cancer Drugs·R Duncan
Jun 14, 1991·Biochemical and Biophysical Research Communications·S M MoghimiS S Davis
Jan 1, 1988·Biomaterials·S S Davis, L Illum
Apr 20, 1987·Life Sciences·L Illum, S S Davis
Nov 1, 1981·The Journal of Antimicrobial Chemotherapy·R R NewS Heath
Jan 1, 1995·British Medical Bulletin·J P Schofield, C T Caskey
Sep 28, 1995·The New England Journal of Medicine·J M Leiden
Dec 15, 1994·Biochemical and Biophysical Research Communications·P Seth
Nov 1, 1994·American Journal of Respiratory and Critical Care Medicine·F MaltaisS B Gottfried
May 15, 1992·Physical Review. B, Condensed Matter·Y C JeanC W Chu

❮ Previous
Next ❯

Citations

Aug 19, 2007·Journal of Materials Science. Materials in Medicine·Yan Hua XueShi Long Wang
Aug 19, 2011·Applied Biochemistry and Biotechnology·Mainak ChakrabortyVibha Rani
Mar 3, 2012·Biological Trace Element Research·Min-Qi WangYong-Jie Du
Jun 7, 2005·Bioorganic & Medicinal Chemistry Letters·Christian GirardDaniel Scherman
Feb 26, 2013·Cancer Letters·Farrukh AqilManicka V Vadhanam
Dec 31, 2003·International Journal of Pharmaceutics·Catherine C BerryAdam S G Curtis
May 18, 2005·International Journal of Pharmaceutics·E Garcia-GarciaP Couvreur
Mar 12, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kumiko UedaSeigo Iwakawa
Feb 26, 2003·Journal of Colloid and Interface Science·Thomas TrimailleThierry Delair
Mar 6, 2003·Journal of Colloid and Interface Science·Dhruba Jyoti BharaliAmarnath Maitra
Feb 19, 1999·Biochimica Et Biophysica Acta·D Y KwohD J Carlo
Feb 22, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·H M RedheadL Illum
Aug 23, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·U RungsardthongS Stolnik
Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·S MitraA N Maitra
Sep 2, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·V HuterW Lubitz
Aug 16, 2000·Advanced Drug Delivery Reviews·S R WinnJ O Hollinger
Mar 12, 2003·Advanced Drug Delivery Reviews·Sarah L Tao, Tejal A Desai
Jun 6, 2000·Advanced Drug Delivery Reviews·R J LevyJ Bonadio
Jun 19, 2002·Bio Systems·Katarzyna Bogunia-Kubik, Masanori Sugisaka
Mar 19, 2002·International Journal of Pharmaceutics·Jasmine Davda, Vinod Labhasetwar
Dec 14, 2002·International Journal of Pharmaceutics·Indrajit RoySubho Mozumdar
Dec 18, 2003·Drug Discovery Today·Sanjeeb K Sahoo, Vinod Labhasetwar
Mar 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·Adela C BonoiuParas N Prasad
May 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Krishnan V ChakravarthyParas N Prasad
Feb 26, 2010·Nucleosides, Nucleotides & Nucleic Acids·Sen HouXi-Zeng Feng
Jul 24, 2012·Journal of Nanobiotechnology·Md FakruddinHafsa Afroz
Mar 10, 2012·International Journal of Nanomedicine·Tuck-yun CheangShen-ming Wang
May 1, 2013·International Journal of Nanomedicine·Satya Ranjan SarkerShinji Takeoka
Aug 24, 2007·AJR. American Journal of Roentgenology·Sang Min LeeMyung Jin Shin
Nov 14, 2007·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·Yan WangWei-jia Cao
Jul 30, 2005·Proceedings of the National Academy of Sciences of the United States of America·Dhruba J BharaliMichal K Stachowiak
Jun 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·Huajian GaoLambert B Freund
Jan 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Indrajit RoyParas N Prasad
Apr 18, 2014·Journal of the Royal Society, Interface·Priyanka BhattacharyaYuehe Lin
Jul 2, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Frank Alexis
Mar 26, 2005·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Jun LiuLi-Jian Zhao
Mar 12, 2015·Journal of Drug Targeting·Abhijeet D KulkarniChandrakantsing V Pardeshi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.